<DOC>
	<DOCNO>NCT02092909</DOCNO>
	<brief_summary>Recent report identify specific oncogenic mutation L265P MYD88 gene approximately 90 % patient Waldenström 's macroglobulinemia . MYD88 key linker protein signal pathway Toll Like Receptors ( TLRs ) 7 , 8 , 9 , IMO-8400 oligonucleotide specifically design inhibit TLRs 7,8 , 9 . The scientific hypothesis use IMO-8400 treat patient Waldenström 's macroglobulinemia depend inhibition mutant MYD88 signal TLR pathway , thereby interrupt proliferation cell population responsible propagation disease .</brief_summary>
	<brief_title>Phase 1/2 Dose Escalation Study Patients With Relapsed Refractory Waldenstrom 's Macroglobulinemia</brief_title>
	<detailed_description>Eligible subject enrol assigned escalate dose cohort . Treatment administer subcutaneous injection .</detailed_description>
	<mesh_term>Waldenstrom Macroglobulinemia</mesh_term>
	<criteria>Patients must diagnosis relapse Waldenstrom 's Macroglobulinemia . In addition , key inclusion exclusion criterion list . 1 . At least 18 year age . 2 . Agree use contraception 3 . Hemoglobin ≥ 7.5 g/dL , Absolute neutrophil count ≥ 1.0 x 109/L ( 1000/mm3 ) , Platelets ≥ 50,000/μL 1 . Is nurse pregnant 2 . Has BMI &gt; 34.9 kg/m2 . 3 . Has positive test human immunodeficiency virus ( HIV1 2 ) hepatitis C virus ( HCV ) hepatitis B surface antigen ( HBsAg ) . 4 . Receiving chronic systemic corticosteroid therapy &gt; 20 mg prednisone daily . 5 . Being treated anticancer therapy ( approved investigational ) . 6 . Has , initiation study drug , receive cytotoxic chemotherapy Bruton 's tyrosine kinase ( BTK ) inhibitor ( e.g . ibrutinib ) within past 3 week rituximab within past 2 month 7 . Has active infection require systemic antibiotic . 8 . Has surgery require general anesthesia within 4 week start study . 9 . Has autoimmune cytopenia ( anemia , thrombocytopenia , leukopenia ) . 10 . Has heart failure Class III IV . 11 . Has sensory motor neuropathy limit daily activity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>